Latest Neuroregeneration Stories
Full Nerve Repair Product Portfolio Now Approved in Europe Alachua, FL (PRWEB) May 01, 2013 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced European CE Mark approval for two of its nerve repair products, AxoGuard® Nerve Protector and AxoGuard® Nerve Connector. AxoGuard® Nerve Connector and AxoGuard® Nerve...
Data from on-going Ranger® Registry to be Poster Presentations at Major Plastic Surgery Conference Alachua, FL (PRWEB) April 19, 2013 AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today the presentation of two posters submitted by study investigators based on clinical use of Avance® Nerve Graft at the American Association...
Physician Education Event Highlights New Treatment Options for Trigeminal Nerve Repair. Alachua, FL (PRWEB) April 16, 2013 AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it is sponsoring a panel discussion on nerve repair and protection at the American College of Oral and Maxillofacial Surgeons (ACOMS) 2013 Annual...
AxoGen’s Avance® Nerve Graft technology to be discussed in educational session on peripheral nerve allograft Alachua, FL (PRWEB) April 03, 2013 AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it will be participating in the American Association of Tissue Banks (AATB) 2013 Spring Meeting, April 6-9 in Tucson,...
Penn State Building a tunnel made up of both hard and soft materials to guide the reconnection of severed nerve endings may be the first step toward helping patients who have suffered extensive nerve trauma regain feeling and movement, according to a team of biomedical engineers. "Nerve injury in both central nervous system and peripheral nervous system is a major health problem," said Mohammad Reza Abidian, assistant professor of biomedical engineering, Penn State. "According to the...
A gene that is associated with regeneration of injured nerve cells has been identified by scientists at Penn State University and Duke University. The team, led by Melissa Rolls, an assistant professor of biochemistry and molecular biology at Penn State, has found that a mutation in a single gene can entirely shut down the process by which axons -- the parts of the nerve cell that are responsible for sending signals to other cells -- regrow themselves after being cut or damaged. "We are...
Finding the 'master knob to turn on nerve repair' Modulating immune response to injury could accelerate the regeneration of severed peripheral nerves, a new study in an animal model has found. By altering activity of the macrophage cells that respond to injuries, researchers dramatically increased the rate at which nerve processes regrew. Influencing the macrophages immediately after injury may affect the whole cascade of biochemical events that occurs after nerve damage, potentially...
The abstract submission titled “Clinical Results from a Multicenter Registry Study on the Use of Processed Nerve Allograft for Sensory, Mixed and Motor Nerve Repairs” was selected for an Outstanding award and poster display at AATB 2012 Annual Meeting. Alachua, FL (PRWEB) September 07, 2012 AxoGen Inc., Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today that its submission titled “Clinical Results from...
Attendees at ASSH 2012 are invited to join AxoGen to “Thank a Wounded Warrior” and donate to the Wounded Warrior Project. Alachua, FL (PRWEB) September 06, 2012 AxoGen, Inc. (OTCBB: AXGN) announced today that it has launched an initiative to support wounded warriors with the “Thank a Wounded Warrior” program at the American Society for Surgery of the Hand 2012 Meeting, September 6-8, in Chicago. Participants attending ASSH are invited to join AxoGen employees in Booth 1112 and...
AxoGen to support educational events at ASSH 2012 featuring presentations by clinical experts on use of pioneering regenerative technologies in peripheral nerve repair. Alachua, FL (PRWEB) September 05, 2012 AxoGen, Inc. (OTCBB: AXGN), a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today that Avance ® Nerve Graft, a processed nerve allograft for surgical repair and reconstruction of peripheral nerve segmental defects, will...
